Intuitive Surgical Inc (ISRG) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Intuitive Surgical Inc   (NASDAQ: ISRG)


Intuitive Surgical Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Intuitive Surgical Inc's ROI in the second quarter of 2026?
Intuitive Surgical Inc achieved a return on average invested assets (ROI) of 17.11 % in its second quarter of 2026, this is above ISRG's average return on investment of 16.45%.
Intuitive Surgical Inc s investments during the 12 months ending in the second quarter of 2026 are valued at $18 billion

Despite the deterioration in its net income, company has improved ROI compared to the first quarter of 2026.

Within the Healthcare sector 62 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 437 to 439.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 6.05 % 10.62 % 15.46 % 18.88 % 22.61 %
Y / Y Net Income Change TTM 20.23 % 20.25 % 60.69 % 150.89 % 394.17 %
Investment (TTM) in Millions 19,083 18,323 18,764 17,661 18,578
Return On Investment (TTM) 17.11 % 16.36 % 15.81 % 15.55 % 15.09 %
ISRG's Overall Ranking # 439 # 437 # 422 # 449 # 394
Seq. Investment Change TTM 0.69 % 0.74 % 2.35 % 2.15 % 5.02 %
Seq. Net Income Change TTM 5.3 % 4.25 % 4.03 % 5.28 % 5.32 %
Net Income (TTM) in Millions 3,158 2,999 2,877 2,765 2,627




Return On Investment ISRG's Ranking
Within: No.
Industry # 12
Sector # 63
Overall # 439

Return On Investment Statistics
High Average Low
48.75 %
16.45 %
10.99 %
(Dec. 31, 2006)   (Dec 31 2022)







Financial Statements
Intuitive Surgical Inc's II. Quarter Investments $ 19,083 Millions ISRG's Balance sheet
Intuitive Surgical Inc's II. Quarter Income $ 823 Millions Quarterly ISRG's Income Statement
ISRG's Income by Division See ISRG's Income by Division


ISRG Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 18,570 17,094 13,873 11,623 12,456
Y / Y Investment Growth 8.64 % 23.22 % 19.36 % -6.69 % 21.74 %
Net Income in Millions 2,877 2,338 1,817 1,344 1,728
Y / Y Net Income Growth 23.06 % 28.62 % 35.18 % -22.2 % 61.99 %
Annual Return On Investment 15.49 % 13.67 % 13.1 % 11.57 % 13.87 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 15.49 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ISRG's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ISRG's Competitors
Subscribers only: Roi for Intuitive Surgical Inc's Suppliers
Subscribers only: Return On Investment for ISRG's Customers

Other Ratios
ISRG's Roa ISRG's Inventory Turnover Ratio ISRG's Growth Rates ISRG's Dividend Statistics
ISRG's Profitability Ratios ISRG's Asset Turnover Ratio ISRG's Dividend Growth
ISRG's Roe ISRG's Valuation Ratios ISRG's Financial Strength Ratios ISRG's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Vaxart Inc   46.17 %
Liquidia Corporation  42.09 %
Tg Therapeutics Inc   39.26 %
Medpace Holdings Inc   35.54 %
Mettler toledo International Inc   34.41 %
Eli Lilly And Company  33.95 %
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %


Date modified: 2026-07-23T01:57:36+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.